OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy
Yujia Chen, Guan-Nan Li, Xian-Jing Li, et al.
Science Advances (2023) Vol. 9, Iss. 17
Open Access | Times Cited: 84

Showing 26-50 of 84 citing articles:

IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway
Menghua Zhou, Hongjun Yu, Miaoyu Bai, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 777-790
Open Access | Times Cited: 7

Leveraging macrophage metabolism for anticancer therapy: opportunities and pitfalls
Piyal Saha, Paul Ettel, Thomas Weichhart
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 4, pp. 335-349
Open Access | Times Cited: 6

Drug resistance and tumor immune microenvironment: An overview of current understandings (Review)
Yan Liu, Jun Liang, Yanping Zhang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 4
Open Access | Times Cited: 6

Metabolite itaconate in host immunoregulation and defense
Wenchang Yang, Yaxin Wang, Kaixiong Tao, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 15

Breaking the stromal barrier in pancreatic cancer: Advances and challenges
Mohana Chakkera, Jeremy B. Foote, Batoul Farran, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189065-189065
Closed Access | Times Cited: 14

Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
Lei Liu, Genwang Chen, Sisi Gong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13

The potential therapeutic role of itaconate and mesaconate on the detrimental effects of LPS-induced neuroinflammation in the brain
Melanie Ohm, Shirin Hosseini, Niklas Lonnemann, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5

Tumor-Associated Senescent Macrophages, Their Markers, and Their Role in Tumor Microenvironment
Tamara V. Pukhalskaia, Taisiya R. Yurakova, Daria A. Bogdanova, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 5, pp. 839-852
Closed Access | Times Cited: 4

Oncometabolites in cancer: from cancer cells to the tumor microenvironment
Luoyi Chen, Min Huang
Holistic Integrative Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 4

Targeting GSDME-mediated macrophage polarization for enhanced antitumor immunity in hepatocellular carcinoma
Shiping Chen, Peiling Zhang, Gui‐Qi Zhu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1505-1521
Closed Access | Times Cited: 4

From silent partners to potential therapeutic targets: macrophages in colorectal cancer
Hayat Khizar, Kamran Ali, Jianwei Wang
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access

Myeloid cells: key players in tumor microenvironments
Qiaomin Hua, Zhixiong Li, Yulan Weng, et al.
Frontiers of Medicine (2025)
Closed Access

Extracellular vesicles as natural nanocarriers: From in vitro engineering to in situ generation in cancer therapy
Teng Zhang, Zimai Liu, Yuanyuan Wei, et al.
Chemical Engineering Journal (2025), pp. 161653-161653
Closed Access

Damage-associated molecular patterns as metabolic regulators of innate immunity
Tristram A.J. Ryan, Ivan Zanoni, Marco Di Gioia
Elsevier eBooks (2025), pp. 129-155
Closed Access

Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target
Guorong Zhang, Hanzhi Yu, Jingjing Liu, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115631-115631
Closed Access

Itaconate: A Potential Therapeutic Strategy for Autoimmune Disease
Yifan Xie, Qi Cheng, Meng Xu, et al.
Scandinavian Journal of Immunology (2025) Vol. 101, Iss. 5
Closed Access

Metabolic regulation of innate immunity in cancer immunotherapy
Yuheng Liao, Hui Yang
Cancer Biology and Medicine (2024) Vol. 20, Iss. 12, pp. 898-902
Open Access | Times Cited: 3

Tumor-associated macrophages within the immunological milieu: an emerging focal point for therapeutic intervention
Yanchi Shao, Song‐Hee Han, Zhenxin Hou, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e36839-e36839
Open Access | Times Cited: 3

Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity
Z. H. Wang, Lei Cui, Yanxun Lin, et al.
The EMBO Journal (2024)
Open Access | Times Cited: 3

Deciphering metabolic crosstalk in context: lessons from inflammatory diseases
F.W. Verheijen, Thi Nga Tran, Jung‐Chin Chang, et al.
Molecular Oncology (2024) Vol. 18, Iss. 7, pp. 1759-1776
Open Access | Times Cited: 2

Scroll to top